Potential policy changes and the expected impact on all stakeholders

In this discussion moderated by Sean Sullivan, Professor of Pharmacy and Public Health at the University of Washington, panelists Cate Lockhart, Executive Director of the Biologics and Biosimilars Consortium, and Sophia Humphreys, Executive Director, Pharmacy, Credena, Providence Health, offer stakeholder perspectives on biosimilar sustainability, from current threats to upcoming policy reforms that could strengthen biosimilar viability in time.

Format: Podcast (22.31)

Presented by Pfizer

Posted 5/24